Seminars in Oncology

The Changing Landscape of Prostate Cancer

Prostate cancer is the most common non-cutaneous malignancy in men, accounting for more than 28,000 deaths in the United States every year; however, how to prevent, diagnosis, and treat prostate cancer remains one of the most debatable topics in oncology today. Read More »

Molecular Pathogenesis and Progression of Prostate Cancer

Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous malignancy and second leading cause of cancer-related deaths in US males. Clinically, locally confined disease is treated surgically and/or with radiation therapy. Read More »

Molecular Diagnosis of Prostate Cancer: Are We Up to Age?

Prostate cancer (PCa), a highly heterogeneous disease, is the one of the leading cause of morbidity and mortality in the developed countries. Historically used biomarkers such as prostatic acid phosphatase (PAP), serum prostate-specific antigen (PSA), and its precursor have not stood the challenge of sensitivity and specificity. Read More »